World Summit on Heart, Stroke and Neurological Disorders (Stroke Summit 2018)

On behalf of the programme committee, we extend our warmest welcome to the “World Summit on Heart, Stroke and Neurological Disorders, August 31- September 01, 2018 Boston, USA. Stroke Summit 2018 is a unique meeting that unites cardiologists and neurologists in order to pursue a holistic approach in the rapidly growing fields of Cardiology and Neurology for improved practice, research, education, recovery and patient care. This gathering is predominantly will focus the most recent and energizing developments in each range of Cardiology and Stroke research, and it will offer an exceptional opportunity for specialists from all over the world to meet, network, and distinguish with different scientific interactions.

Being held in the breath-taking city of Boston, Stroke Summit 2018 will be the ideal meeting point ​for the leading Neurologists, Neuroscientists, Neurosurgeons, Neuroradiologists, Interventional radiologists,  Cardiologists, Cardiac surgeons, Physiatrists, Emergency medicine specialists,  International speakers, Scientists, Researchers, University Professors, Students, College Faculty members, Primary care Physicians, Hospitalists, Nurses and Nurse practitioners, Rehabilitation specialists, Physical, Occupational and speech Therapists, Pharmacists, Business Entrepreneurs, Healthcare professionals and investigators to meet, network with different medical and scientific interactions. As a special designed cluster forum of Keynote talks, Plenary sessions, Workshops and Symposia along with Oral and Poster presentations, panel discussions with round table sessions focusing on interdisciplinary aspects as well as current and future concepts for epidemiology, research, prevention, and treatment of Neurological disorders like Stroke, Paediatric stroke, Nursing, Neurocritical care, Alzheimer’s and Dementia and Cardiovascular diseases like Cardiac arrest, Coronary heart disease, Congestive heart failure, diagnostic methods/devices, biomarkers and on-going Clinical trials..